HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease

IntroductionIn Krabbe disease (KD), mutations in β-galactosylceramidase (GALC), a lysosomal enzyme responsible for the catabolism of galactolipids, leads to the accumulation of its substrates galactocerebroside and psychosine. This neurologic condition is characterized by a severe and progressive de...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Sandra O. Braz, Marlene M. Morgado, Marta I. Pereira, Ana C. Monteiro, Olga Golonzhka, Matthew Jarpe, Pedro Brites, Monica M. Sousa, Joana Nogueira-Rodrigues
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2023-07-01
Sarja:Frontiers in Molecular Neuroscience
Aiheet:
Linkit:https://www.frontiersin.org/articles/10.3389/fnmol.2023.1231659/full